Scientific Name: Glucomannan
Other Names: Amorphophallus konjac, Devil's Tongue, Elephant-Foot Yam, Konjac, Konjac Mannan, Konnyaku, Snake Plant

Who is this for?

Uses

Glucomannan is the Western name for vegetable fibers derived from an Asian plant family known as konjac. Glucomannan does not dissolve in water, but forms a thick, gooey gel when exposed to fluids. The body does not digest glucomannan, so the resulting large soft mass moves through the intestines and may trigger intestinal muscle contractions. Therefore, glucomannan is thought to be an effective bulk-type laxative, even though it may take up to 12 hours to be effective.

Glucomannan has also been studied for treating obesity, diabetes, and high cholesterol. Studies in both adults and children with severe obesity showed varying degrees of weight loss associated either with taking supplemental glucomannan or with replacing some of the usual diet with foods made from glucomannan (konjac) flour--the dried and ground tuber (underground stem) of the plant. Generally, glucomannan is believed to discourage overeating because it creates a feeling of fullness after the fiber in it swells. Because stomach contents may stay in the stomach longer, the individual does not feel hungry as often. However, in most of the research studying glucomannan for weight loss, study participants also drank large amounts of water and followed a reduced-calorie diet.

Possibly due to the same delay in stomach emptying, glucomannan may improve blood sugar levels in individuals with diabetes. Because the absorption of carbohydrates from foods is slower when glucomannan is taken, blood sugar levels may not rise as high or as fast as usual. Some preliminary results from animal studies also suggest that glucomannan may increase the sensitivity of body tissues to the insulin that is produced or taken. In several studies, taking glucomannan has also appeared to lower blood levels of total cholesterol, low-density lipoproteins (LDL, or "bad" cholesterol), and triglycerides. Although more research on this possible use of glucomannan is needed, glucomannan may increase the elimination of cholesterol and its components from the body. It may also keep bile acids from being reabsorbed in the intestines, further reducing cholesterol levels in the blood, because the body uses cholesterol to produce more bile.

Precautions

Although glucomannan has been studied in children as young as 5 years old, very little information is available on how glucomannan might affect a developing fetus, an infant, or a small child. Therefore, its use is not recommended during pregnancy, while breast-feeding, or before the age of 5.

Individuals being treated for diabetes should avoid using large amounts of glucomannan unless such use is supervised by a doctor or other healthcare professional. Because glucomannan may lower blood sugar levels, taking it may potentially result in hypoglycemia (blood sugar that is too low). Symptoms of low blood sugar include shakiness, sweating, confusion, distorted speech, and loss of muscle control. If not corrected, low blood sugar can lead to unconsciousness and even death.

What side effects should I watch for?

Glucomannan tablets are not recommended for oral use. Reportedly, several individuals experienced blockage of the esophagus when they took glucomannan in tablet form. The tablets lodged in their throats and swelled when exposed to water. In 2002, the U.S. Food and Drug Administration (FDA) removed jelled candies containing glucomannan from the market after they caused several choking deaths. Children and elderly individuals were especially likely to choke on the candy. Although no cases have been reported, the potential for a similar blockage of the intestines exists.

One case of allergic pneumonia caused by inhaling glucomannan dust has been documented in an individual who worked for over 35 years in a factory that produced glucomannan powder.

What interactions should I watch for?

Glucomannan's possible lowering effect on blood sugar may intensify the effects of insulin and oral drugs for diabetes, such as:

• acarbose
• Actos
• Avandia
• glimepride
• glipizide
• glyburide
• Glyset
• metformin
• Prandin

When mixed with water or other fluids, glucomannan forms a sticky, slippery gel that may coat the stomach and intestines. In theory, taking glucomannan by mouth could block the absorption of drugs, herbal products, other dietary supplements, or nutrients from foods that are taken at the same time. Those who take glucomannan should not take drugs, herbals, or dietary supplements within 2 hours.

Because glucomannan may decrease blood sugar levels, taking it with other blood sugar-lowering herbal products may result in hypoglycemia--blood sugar that is too low. Herbals that may reduce blood sugar include:

• Eleuthero
• Fenugreek
• Ginger (in high amounts)
• Kudzu
• Panax Ginseng

Some interactions between herbal products and medications can be more severe than others. The best way for you to avoid harmful interactions is to tell your doctor and/or pharmacist what medications you are currently taking, including any over-the-counter products, vitamins, and herbals. For specific information on how glucomannan interacts with drugs, other herbals, and foods and the severity of those interactions, please use our Drug Interactions Checker to check for possible interactions.

Should I take it?

Glucomannan is a plant that grows mainly in Asia where it is known as konjac. A closely related species is called elephant-foot yam due to the exceptionally large tuber (an enlarged underground extension of the plant stem) that it produces. Each glucomannan plant produces one large tuber similar to a beet. Unlike most plants with roots that extend from the bottom of the tuber, glucomannan's roots grow from the top of the tuber, which also puts out one thick stem. Each glucomannan stem in turn, has only one leaf. A single, large, showy, but foul-smelling flower may bloom before the leaf appears. Depending on the species, the leaf may be multi-lobed or single. Glucomannan may be called snake plant because blotchy green, white, yellow, and/or brown markings on the stems resemble snake skin. Its tubers, which are usually harvested in the autumn from three-year old plants, can grow up to 10 or more pounds.

In Asia, glucomannan tubers are used widely as food. Fresh glucomannan tubers can be sliced and fried like potato chips. They may also be baked, boiled, stewed, or added to soup. Frequently, the tubers are shredded, dried, and ground to make a grainy meal (for cereal) or a powdery flour, which is often used to make noodles. Glucomannan meal or flour may also replace part of the corn meal, wheat flour, or rice flour used in cooking and baking. Mannose, a sugar extracted from glucomannan, sometimes is substituted for sugar in products for individuals with diabetes and glucomannan is used like tofu in vegetarian dishes. In Japan, a popular type of jelled candy called konnyaku is made from glucomannan.

Glucomannan has other uses, as well. A liquid form has been tested as a preservative to control bacteria that may contaminate other foods. Powdered glucomannan is used to thicken cosmetics, foods, and pharmaceuticals. Since it is broken down and absorbed in the colon instead of in the upper digestive tract where most other foods are digested, glucomannan is being studied as a way to deliver drugs to the large intestines for treating conditions such as irritable bowel syndrome. Because it is not irritating, glucomannan has also been included in artificial skin products that are used to cover large wounds and promote healing.

Dosage and Administration

Note: Taking glucomannan tablets has been associated with occasional life-threatening blockages of the throat. Individuals who decide to use it should either take capsules and swallow them with plenty of water or use a glucomannan powder that is mixed into fluids before swallowing. Glucomannan should always be taken with 8 ounces or more of water or other fluid.

In the United States, glucomannan capsules generally come in 500 mg or 650 mg strengths. Common dosing instructions are to take the recommended dose one hour to one-half hour before meals.

Common doses used in studies have included:

Use	Dose	Frequency
Laxative	3,000 mg to 4,000 mg (3 grams to 4 grams)	Once. Repeated after 12 hours, if necessary
Diabetes	3,600 mg to 7,200 mg (3.6 grams to 7.2 grams)	Once a day
High Cholesterol	3,900 mg (3.9 grams)	Once a day
Weight loss (Adults)	1,000 mg (one gram)	Three times a day
Weight loss (Children)	700 mg to 1,000 mg (0.7 grams to one gram)	Three times a day

Summary

Glucomannan, the fiber obtained from the tubers of the konjac plant, is used mainly as a laxative. It may also encourage weight loss, help to lower blood sugar levels, and lessen cholesterol in the blood.

Risks

Individuals with diabetes should not take glucomannan due to possible changes in blood sugar that it may cause. Children under the age of 5 and women who are pregnant or breastfeeding may want to avoid using glucomannan, as well.

Side Effects

In tablet form, glucomannan has been associated with esophageal blockages.

Interactions

Glucomannan's potential decreasing effect on blood sugar may increase the effects of drugs or herbs that also lower blood sugar.

Last Revised April 11, 2008

References

Alvarez-Mancenido F, Braeckmans K, De Smedt SC, Demeester J, Landin M, Martinez-Pacheco R. Characterization of diffusion of macromolecules in konjac glucomannan solutions and gels by fluorescence recovery after photobleaching technique. International Journal of Pharmacy. 2006;316(1-2):37-46.

Alvarez-Mancenido F, Landin M, Lacik I, Martinez-Pacheco R. Konjac glucomannan and konjac glucomannan/xanthan gum mixtures as excipients for controlled drug delivery systems. Diffusion of small drugs. International Journal of Pharmacy. 2008;349(1-2):11-18.

Alvarez-Mancenido F, Landin M, Martinez-Pacheco R. Konjac glucomannan/xanthan gum enzyme sensitive binary mixtures for colonic drug delivery. European Journal of Pharmacy and Biopharmacy. Epublished ahead of print. January 15, 2008.

Anon. Glucomannan. In: DerMarderosian A, Beutler JA, eds. Facts and Comparisons: The Review of Natural Products. St. Louis, MO, Facts and Comparisons. August 1995.

Anon. Evaluation of certain food additives and contaminants. Forty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organization Technical Reporting Service. 1997;868:i-viii and 1-69.

Arvill A, Bodin L. Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men. American Journal of Clinical Nutrition. 1995;61(3):585-589.

Azezli AD, Bayraktaroglu T, Orhan Y. The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism. Journal of the American College of Nutrition. 2007;26(6):663-668.

Birketvedt GS, Shimshi M, Erling T, Florholmen J. Experiences with three different fiber supplements in weight reduction. Medical Science Monitor. 2005;11(1):PI5-PI8.

Boban PT, Nambisan B, Sudhakaran PR. Hypolipidaemic [sic] effect of chemically different mucilages in rats: a comparative study. British Journal of Nutrition. 2006;96(6):1021-1029.

Cairella M, Marchini GAD. Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients. [Article in Italian] Clinical Therapeutics. 1995;146(4):269-274.

Chearskul S, Sangurai S, Nitiyanant W, et al. Glycemic and lipid responses to glucomannan in Thais with type 2 diabetes mellitus. Journal of the Medical Association of Thailand. 2007;90(10):2150-2157.

Chen HL, Cheng HC, Liu YJ, Liu SY, Wu WT. Konjac acts as a natural laxative by increasing stool bulk and improving colonic ecology in healthy adults. Nutrition. 2006;22(11-12):1112-1119.

Chen HL, Sheu WH, Tai TS, Liaw YP, Chen YC. Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects--a randomized double-blind trial. Journal of the American College of Nutrition. 2003;22(1):36-42.

Frieri G, Pimpo MT, Scarpignato C. Management of colonic diverticular disease. Digestion. 2006;73(Suppl 1):58-66.

Huang CY, Zhang MY, Peng SS, et al. Effect of Konjac food on blood glucose level in patients with diabetes. Biomedical and Environmental Science. 1990;3(2):123-131.

Jellin JM, Gregory P, Batz F, Hitchens K, et al, eds. Pharmacist's Letter/Prescriber's Letter. Natural Medicines Comprehensive Database, 3rd Edition. Stockton CA: Therapeutic Research Facility, 2000.

Joint FAO/WHO Expert Committee on Food Additives (JECFA). Konjac flour. Food Additives (uses other than as flavouring [sic] agents) Database. Available at: http://apps3.fao.org/jecfa/additive_specs/docs/4/additive-0623.htm Accessed September 23, 2003.

Kaur M, Agarwal R, Agarwal C. Grape seed extract induces anoikis and caspase-mediated apoptosis in human prostate carcinoma LNCaP cells: possible role of ataxia telangiectasia mutated-p53 activation. Molecular Cancer Therapy. 2006;5(5):1265-1274.

Keithley J, Swanson B. Glucomannan and obesity: a critical review. Alternative Therapy in Health Medicine. 2005;11(6):30-34.

Kitamoto N, Kato Y, Ohnaka T, Yokota M, Tanaka T, Tsuji K. Bactericidal effects of konjac fluid on several food-poisoning bacteria. Journal of Food Protection. 2003;66(10):1822-1831.

Kitamoto N, Tanaka T, Kato Y, Tsuji K. Bactericidal effects of konjac fluid against enterohemorrahgic Escherichia coli O 157:H7. Journal of the Japanese Journal of Food Chemistry. 2000;7(2):86-92.

Liu X, Wang K, Ding Y, He X, Wang B. Restoring the skin from traumatism by means of collagen-konjac glucomannan-chondroitin sulfate blend film. [Article in Chinese] Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2005;22(5):1004-1006 and 1023.

Livieri C, Novazi F, Lorini R. The use of highly purified glucomannan-based fibers in childhood obesity. [Article in Italian] Pediatric Medicine and Surgery. 1992;14(2):195-198.

Loening-Baucke V, Miele E, Staiano A. Fiber (glucomannan) is beneficial in the treatment of childhood constipation. Pediatrics. 2004;113(3 Pt 1):e259-e264.

Mao CP, Xie ML, Gu ZL. Effects of konjac extract on insulin sensitivity in high fat diet rats. Acta Pharmacol Sin. 2002;23(9):855-859.

Martino F, Martino E, Morrone F, Carnevali E, Forcone R, Niglio T. Effect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercholesterolemic children. Nutrition, Metabolism and Cardiovascular Disease. 2005;15(3):174-180.

Nakano M, Takikawa K, Arita T. Release characteristics of dibucaine dispersed in konjac gels. Journal of Biomedical Materials Research. 1979;13(5):811-819.

Natural Medicines Comprehensive Database, Online Edition. Pharmacist's Letter/Prescriber's Letter. Stockton CA: Therapeutic Research Facility, 2006. Available at: http://www.pharmacistsletter.com/(S(ulqz3s45omt3ag55um4kj345))/home.aspx?li=1&st=1&cs=&s=ND.

Onishi N, Kawamoto S, Ueda K, et al. Dietary pulverized konjac glucomannan prevents the development of allergic rhinitis-like symptoms and IgE response in mice. Bioscience, Biotechnology and Biochemistry. 2007;71(10):2551-2556.

Oomizu S, Onishi N, Suzuki H, et al. Oral administration of pulverized Konjac glucomannan prevents the increase of plasma immunoglobulin E and immunoglobulin G levels induced by the injection of syngeneic keratinocyte extracts in BALB/c mice. Clinical and Experimental Allergy. 2006;36(1):102-110.

Pittler MH, Ernst E. Dietary supplements for body-weight reduction: a systematic review. American Journal of Clinical Nutrition. 2004;79(4):529-536.

Ruszova E, Pavek S, Hajkova V, et al. Photoprotective effects of glucomannan isolated from Candida utilis. Carbohydrate Research. 2008;343(3):501-511.

Salas-Salvado J, Farres X, Luque X, et al; for the Fiber in Obesity-Study Group. Effect of two doses of a mixture of soluble fibres [sic] on body weight and metabolic variables in overweight or obese patients: a randomised [sic] trial. British Journal of Nutrition. 2008;99(6):1380-1387.

Shima K, Tanaka A, Ikegami H, Tabata M, Sawazaki N, Kumahara Y. Effect of dietary fiber, glucomannan, on absorption of sulfonylurea in man. Hormone and Metabolic Research. 1983;15(1):1-3.

Shimizu H, Yamauchi M, Kuramoto T, Kubota N, Matsuda M, Hoshita T. Effects of dietary konjac mannan on serum and liver cholesterol levels and biliary bile acid composition in hamsters. Journal of Pharmacobiodynamics. 1991;14(7):371-375.

Tajima S, Kon H, Oshikawa K, Bando M, Ohno S, Sugiyama Y. Hypersensitivity pneumonitis induced by Konjak flour and powdered Hijikia fusiforme. Internal Medicine. 2003;42(9):846-849.

Talt M. Wild, wonderful aroids -- part 3 -- amorphophallus. In: Talt M, ed. Gardening in Shade. Suite 101. December 2, 2002. Available at: http://www.suite101.com/article.cfm/222/96575. Accessed September 23, 2003.

U.S. Food and Drug Administration. Konjac candy recalls. Updated November 6, 2002. Available at: http://www.fda.gov/oc/po/firmrecalls/topics/konjac.html. Accessed April 14, 2008.

Vanderbeek PB, Fasano C, O'Malley G, Hornstein J. Esophageal obstruction from a hygroscopic pharmacobezoar containing glucomannan. Clinical Toxicology (Philadelphia). 2007;45(1):80-82.

Vido L, Facchin P, Antonello I, Gobber D, Rigon F. Childhood obesity treatment: double blinded trial on dietary fibres (glucomannan) versus placebo. Padiatr Padol. 1993;28(5):133-136.

Vita PM, Restelli A, Caspani P, Klinger R. Chronic use of glucomannan in the dietary treatment of severe obesity. [Article in Italian] Minerva Med. 1992;83(3):135-139.

Vuksan V, Jenkins DJ, Spadafora P, et al. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care. 1999;22(6):913-919.

Vuksan V, Sievenpiper JL, Owen R, et al. Beneficial effects of viscous dietary fiber from konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care. 2000;23(1):9-14.

Vuksan V, Sievenpiper JL, Xu Z, et al. Konjac-mannan and American ginsing [sic]: emerging alternative therapies for type 2 diabetes mellitus. Journal of the American College of Nutrition. 2001;20(5 Suppl):370S-383S.

Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study. International Journal of Obesity. 1984;8(4):289-293.

Wang B, Wang K, Dan W, Zhang T, Ye Y. Konjac glucomannan-collagen-chitosan blend films (I). [Article in Chinese] Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2006;23(1):102-106.

Wang Z, Yang L, Liu H, Tan X. Effects of refined konjac meal on lipid metabolism and blood viscosity of rats fed by high fat forage. [Article in Chinese] Wei Sheng Yan Jiu. 2002;31(2):120-121.

Woo GH, Shibutani M, Kuroiwa K, et al. Lack of preventive effects of dietary fibers or chlorophyllin against acrylamide toxicity in rats. Food Chemistry and Toxicology. 2007;45(8):1507-1515.

Wright TI, Spencer JM, Flowers FP. Chemoprevention of nonmelanoma skin cancer. Journal of the American Academy of Dermatology. 2006;54(6):933-946.

Wu J, Peng SS. Comparison of hypolipidemic effect of refined konjac meal with several common dietary fibers and their mechanisms of action. Biomedical and Environmental Science. 1997;10(1):27-37.

Yoshida M, Vanstone CA, Parsons WD, Zawistowski J, Jones PJ. Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes. European Journal of Clinical Nutrition. 2006;60(4):529-537.

Zhang Y, Hou SX, Lu Y, Chen G, Ju JH. Study on preparation of konjac glucomannan-hydroxypropyl methyl cellulose compression coated tablets for colonic delivery and in vitro release. [Article in Chinese] Zhongguo Zhong Yao Za Zhi. 2006;31(8):642-645.

Zhang MY, Huang CY, Wang X, Hong JR, Peng SS. The effect of foods containing refined Konjac meal on human lipid metabolism. Biomedical and Environmental Science. 1990;3(1):99-105.

Zhu GQ, Zhang Y, Liu JH. Studies on drug release from aminophylline konjac glucomannan matrix tablet. [Article in Chinese] Zhongguo Zhong Yao Za Zhi. 2007;32(21):2236-2239.

Last Revised April 14, 2008

Note: The above information is not intended to replace the advice of your physician, pharmacist, or other healthcare professional. It is not meant to indicate that the use of the product is safe, appropriate, or effective for you.

In general, herbal products are not subject to review or approval by the U.S. Food and Drug Administration (FDA). They are not required to be standardized, meaning that the amounts of active ingredients or contaminants they contain may vary between brands or between different batches of the same brand. Not all of the risks, side effects, or interactions associated with the use of herbal products are known because few reliable studies of their use in humans have been done.

This information is provided for your education only. Please share this information with your healthcare provider and be sure that you talk to your doctor and pharmacist about all the prescription and non-prescription medicines you take before you begin to use any herbal product.

Back